225-Actinium-PNT-2004

N/A

Report date: 2025/12/02 14:07:07

NME

Base Information

Drug Name225-Actinium-PNT-2004

Drug Alias Name225-Ac-PNT-2004PNT-2004

ClassificationRadiation-emitting products > Nuclides > Actinium > 225AcRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionIonising radiation emittersFibroblast activation protein alpha antagonistsPositron-emission tomography enhancers +[4]

TargetsProlyl endopeptidase FAP

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPoint Biopharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesPoint Biopharma Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A